BRD4 and cancer: The recent identification of Brd4 inhibitors including JQ1 and I-BET provides great potential for treatment of HPV-induced cancers as both inhibitors target bromodomains [68,69] and prevent them from binding to acetylated histones and to act as transcriptional activators [70].